Clinical trial
A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic…
NCT00153868 · Dartmouth-Hitchcock Medical Center, Other · Completed
Key facts
| NCT number | NCT00153868 |
|---|---|
| Title | A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer |
| Official title | Pilot Web-based Study of Functional Status, Symptom Palliation and Quality of Life Benefits Associated With Darbepoetin Alfa (Aranesp®) Administration in Anemic Patients With Cancer. |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Collaborators | Amgen Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia, Cancer |
| Intervention type | Biological |
| Interventions | darbepoetin alfa |
| Enrollment | 43 |
| Start date | Oct 1, 2003 |
| Primary completion | Aug 17, 2007 |
| Completion | Aug 17, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 23, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: